• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 3-(Trifluoromethyl)benzoylacetonitrile (CAS No. 27328-86-5)

3-(Trifluoromethyl)benzoylacetonitrile (CAS No. 27328-86-5) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its trifluoromethyl and benzoylacetonitrile functional groups, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The trifluoromethyl group, a key feature of this compound, is renowned for its ability to enhance metabolic stability and lipophilicity in drug candidates. This property has been extensively leveraged in the development of modern pharmaceuticals, where compounds with trifluoromethyl substitutions often demonstrate improved pharmacokinetic profiles. The presence of the benzoylacetonitrile moiety further contributes to the compound's versatility, enabling diverse chemical transformations that are essential for drug discovery and development.

In recent years, the demand for high-quality intermediates like 3-(trifluoromethyl)benzoylacetonitrile has surged due to advancements in medicinal chemistry. Researchers have increasingly recognized the importance of such intermediates in constructing complex molecular architectures that are critical for achieving desired biological activities. The compound's reactivity and stability make it an indispensable tool in synthetic chemistry, particularly in the preparation of novel heterocyclic compounds and other pharmacologically relevant molecules.

The synthesis of 3-(trifluoromethyl)benzoylacetonitrile typically involves multi-step reactions that require precise control over reaction conditions. The introduction of the trifluoromethyl group often necessitates specialized methodologies, such as halogenation followed by metal-catalyzed cross-coupling reactions. These synthetic routes highlight the compound's role as a building block in advanced chemical transformations.

One of the most compelling applications of 3-(trifluoromethyl)benzoylacetonitrile lies in its use as a precursor for biologically active compounds. For instance, researchers have utilized this intermediate to synthesize inhibitors targeting various therapeutic pathways. The trifluoromethyl group's influence on electronic properties and interactions with biological targets has been particularly valuable in developing drugs with enhanced binding affinities and selectivity.

The benzoylacetonitrile moiety also plays a crucial role in modulating the chemical behavior of the compound. It serves as a versatile handle for further functionalization, allowing chemists to introduce additional substituents or alter existing ones to fine-tune biological activity. This flexibility has made 3-(trifluoromethyl)benzoylacetonitrile a preferred choice for medicinal chemists working on complex drug design challenges.

In conclusion, 3-(trifluoromethyl)benzoylacetonitrile (CAS No. 27328-86-5) is a highly valuable intermediate in pharmaceutical research, offering unique chemical properties that facilitate the synthesis of innovative bioactive molecules. Its widespread use underscores its importance in advancing drug discovery and development efforts worldwide.

• 267880-81-9(3,5-Trifluromethylbenzoylacetonitrile)
• 711-33-1(4'-(Trifluoromethyl)propiophenone)
• 40018-10-8(3-Oxo-3-2-(trifluoromethyl)phenylpropanenitrile)
• 312308-30-8(2-(2-oxo-2-(4-(trifluoromethyl)phenyl)ethyl)malononitrile)
• 85068-34-4(3',5'-Bis(trifluoromethyl)propiophenone)
• 1533-03-5(3'-(Trifluoromethyl)propiophenone)
• 61062-55-3(2-Phenyl-4’-trifluoromethylacetophenone)
• 71682-94-5(3-Oxo-3-4-(trifluoromethyl)phenylpropanenitrile)
• 146653-56-7(2-(4-Cyanophenyl)-3'-trifluoromethylacetophenone)
• 267880-84-2(Benzenepropanenitrile,3-methyl-b-oxo-5-(trifluoromethyl)-)